For the Inventor, By the Inventor

Enter assignee name

Axsome Malta Ltd.

USPTO Granted Patents = 35

EPO Patents = 2

Trademarks = 2

Forward Citations = 36

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Katayoun Zomorodi (13 out of 18 patents)

Herriot Tabuteau (12 out of 407 patents)

Moise A Khayrallah (4 out of 16 patents)

4. Gary Bream (4 out of 16 patents)

5. Stephen E Butts (4 out of 17 patents)

6. Clark Patrick Allphin (3 out of 34 patents)

7. Lawrence Patrick Carter (3 out of 7 patents)

8. Fionn Hurley (3 out of 8 patents)

9. Edwin Gerard Walsh (3 out of 7 patents)

10. Yuan Lu (2 out of 9 patents)

11. Jennifer Leigh Nelson (23 patents)

35 patents: Sort by Forward Citations

1. 12390419 - Formulations of (R)-2-amino-3-phenylpropyl carbamate (2025-08-19),

2. 12384743 - Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof (2025-08-12),

3. 12318362 - Methods of providing solriamfetol therapy to subjects with impaired renal function (2025-06-03),

4. 12263145 - Methods of administering solriamfetol to lactating women (2025-04-01),

5. 12201601 - Treatment for obesity (2025-01-21),

6. 12194016 - Methods of providing solriamfetol therapy to subjects with impaired renal function (2025-01-14),

7. 12162821 - Treatment of cataplexy (2024-12-10),

8. 12102609 - Methods of administering solriamfetol to lactating women (2024-10-01),

9. 12090126 - Methods of administering solriamfetol to lactating women (2024-09-17),

10. 12064411 - Methods of administering solriamfetol to lactating women (2024-08-20),

11. 12036194 - Methods of administering solriamfetol to lactating women (2024-07-16),

12. 12005036 - Methods of administering solriamfetol to lactating women (2024-06-11),

13. 11998639 - Formulations of (R)-2-amino-3-phenylpropyl carbamate (2024-06-04),

14. 11986455 - Methods of providing solriamfetol therapy to subjects with impaired renal function (2024-05-21),

15. 11986454 - Methods of providing solriamfetol therapy to subjects with impaired renal function (2024-05-21),

Axsome Malta Ltd. is a biopharmaceutical company focusing on the development of novel therapies for the treatment of psychiatric and neurological disorders. The company's pipeline includes innovative treatments for depression, Alzheimer's disease, and migraine. Axsome Malta Ltd. is committed to advancing the field of neuroscience through cutting-edge research and clinical trials.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

35 Patents

#1 in Qormi

#4 in Malta

#18,581 in the World

Axsome Malta Ltd.

Forward Citations = 36

11 inventors:

Katayoun Zomorodi (13 out of 18 patents)

Herriot Tabuteau (12 out of 407 patents)

Moise A Khayrallah (4 out of 16 patents)

4. Gary Bream (4 out of 16 patents)

5. Stephen E Butts (4 out of 17 patents)

Please report any incorrect information to support@idiyas.com

Loading…